Clinical Roundup T-cell receptor therapy shows early anti-tumor activity in phase I study January 13, 2023Vol.49 No.02
Clinical Roundup First DKMS clinical trial show practice-changing results for patients with AML January 06, 2023Vol.49 No.01
Clinical Roundup Medicaid expansion improves cancer survival outcomes for young adults, Winship study finds January 06, 2023Vol.49 No.01
Clinical Roundup Phase III trial of TAVT-45 in metastatic prostate cancer yields positive top-line results January 06, 2023Vol.49 No.01
Clinical Roundup Phase III trial of zanidatamab in biliary tract cancers produces positive topline data January 06, 2023Vol.49 No.01
Clinical Roundup Oral paclitaxel combination shows positive results for TNBC subgroup in phase II study January 06, 2023Vol.49 No.01
Clinical Roundup UTSW-led study shows promise for upper urinary tract cancer drug January 06, 2023Vol.49 No.01
Clinical Roundup UTSW immunologists uncover obesity-linked trigger to severe form of liver disease January 06, 2023Vol.49 No.01
Clinical Roundup Interim results from OPTIMIZE-1 phase II study show >50% ORR in pancreatic cancer January 06, 2023Vol.49 No.01
Clinical Roundup IU research points to a biomarker for cardiotoxicity in breast cancer–and a role for dexamethasone January 06, 2023Vol.49 No.01
